Treating Cancer using Targeted Radiotherapeutics with Jack Hoppin and John Babich of Ratio Therap...

Опубликовано: 04 Ноябрь 2024
на канале: Qualio
0

Today we have Dr. Jack Hoppin CEO of Ratio Therapeutics and Dr. John Babich Chief Science Officer of Ratio Therapeutics. The team at Ratio Therapeutics is developing a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancers. They just recently opened a 19,000-square-foot headquarters and R&D facility in Boston to continue their exciting innovation.

We’ll dive into how Ratio started, their growth, and what you can learn from their journey from Lab to Launch.

Show notes:
https://ratiotx.com/ 


Qualio website:
https://www.qualio.com/




Previous episodes:
https://www.qualio.com/from-lab-to-la...




Apply to be on the show:
https://forms.gle/uUH2YtCFxJHrVGeL8




Music by keldez